What should I discuss with my healthcare provider before receiving cytarabine?

Similar documents
MEDICATION GUIDE mitoxantrone (mito-xan-trone) for injection concentrate

MEDICATION GUIDE STELARA

MEDICATION GUIDE POMALYST (POM-uh-list) (pomalidomide) capsules. What is the most important information I should know about POMALYST?

MEDICATION GUIDE. PROCRIT (PRO KRIT) (epoetin alfa)

Share the important information in this Medication Guide with members of your household.

Gemcitabine and Cisplatin

Paclitaxel and Carboplatin

TCH: Docetaxel, Carboplatin and Trastuzumab

Medication Guide EQUETRO (ē-kwĕ-trō) (carbamazepine) Extended-Release Capsules

AC: Doxorubicin and Cyclophosphamide

QUESTIONS TO ASK MY DOCTOR

MEDICATION GUIDE. These serious side effects are described below:

MEDICATION GUIDE ACTOPLUS MET (ak-tō-plus-met) (pioglitazone hydrochloride and metformin hydrochloride) tablets

Patient Guide. Important information for patients starting therapy with LEMTRADA (alemtuzumab)

TC: Docetaxel and Cyclophosphamide

UW MEDICINE PATIENT EDUCATION. Xofigo Therapy. For metastatic prostate cancer. What is Xofigo? How does it work?

IMPORTANT: PLEASE READ

For the Patient: GDP Other names: LYGDP

AUBAGIO Conversation Starter

1. LAMICTAL may cause a serious skin rash that may cause you to be hospitalized or even cause death.

MEDICATION GUIDE WELLBUTRIN (WELL byu-trin) (bupropion hydrochloride) Tablets

Medication Guide Enbrel (en-brel) (etanercept)

Medication Guide TASIGNA (ta-sig-na) (nilotinib) Capsules

MEDICATION GUIDE KOMBIGLYZE XR (kom-be-glyze X-R) (saxagliptin and metformin HCl extended-release) tablets

What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide

CMF: Cyclophosphamide, Methotrexate and Fluorouracil

Treating Chronic Hepatitis C. A Review of the Research for Adults

Patient Medication Guide Brochure

PHARMACIST DETACH HERE AND GIVE TO PATIENT

VAD Chemotherapy Regimen for Multiple Myeloma Information for Patients

MEDICATION GUIDE. ACTEMRA (AC-TEM-RA) (tocilizumab) Solution for Intravenous Infusion

MEDGUIDE SECTION. What is the most important information I should know about SEROQUEL? SEROQUEL may cause serious side effects, including:

Bayer Receives FDA Approval for BETACONNECT First and Only Electronic Autoinjector in Relapsing-Remitting Multiple Sclerosis (RRMS) Treatment

Anthrax vaccine side-effects

CVP Chemotherapy Regimen for Lymphoma Information for Patients

Nonsteroidal. Drugs (NSAIDs) Anti-Inflammatory. North American Spine Society Public Education Series

MEDICATION GUIDE COUMADIN (COU-ma-din) (warfarin sodium)

Medication Guide Plavix (PLAV-iks) (clopidogrel bisulfate) tablets

Presenting the SUTENT Patient Call Center.

It is important that you tell your family and the people closest to you of this increased sensitivity to opioids and the risk of overdose.

LOEWENBERG SCHOOL OF NURSING LOEWENBERG SCHOOL OF NURSING HEALTH EXAMINATION FORM (FORM 003)

Radioactive Ra 223 therapy. Information for patients Weston Park Hospital

MEDICATION GUIDE ELIQUIS (ELL eh kwiss) (apixaban) tablets

What is the most important information I should know about morphine?

Childhood Diseases and potential risks during pregnancy: (All information available on the March of Dimes Web Site.)

For the Patient: Dasatinib Other names: SPRYCEL

Teriflunomide (Aubagio) 14mg once daily tablet

CHOP Chemotherapy Regimen for Lymphoma Information for Patients

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la]

Medication Guide KLONOPIN (KLON-oh-pin) (clonazepam) Tablets

Tuberculosis and You A Guide to Tuberculosis Treatment and Services

Human Normal Immunoglobulin Solution for Intravenous Infusion.

INFLUENZA (FLU) Flu and You

AC Chemotherapy Regimen (Doxorubicin + Cyclophosphamide)

2 P age. Babies from Birth to Age 2

MEDICATION GUIDE. Bupropion Hydrochloride (bue-proe-pee-on HYE-droe-KLOR-ide) Extended-Release Tablets, USP (SR)

MEDICATION GUIDE SYLATRON (SY-LA-TRON) (Peginterferon alfa-2b)

For the Patient: Paclitaxel injection Other names: TAXOL

Do not take Neulasta if you have had a serious allergic reaction to human G-CSFs such as pegfilgrastim or filgrastim products.

MEDICATION GUIDE REMICADE (Rem-eh-kaid) (infliximab) Read the Medication Guide that comes with REMICADE before you receive the first treatment, and

MEDICAL HISTORY AND SCREENING FORM

Women s Continence and Pelvic Health Center

MEDICATION GUIDE. Tranxene* (TRAN-zeen) T-TAB (clorazepate dipotassium) tablets

ORTHOPAEDIC SPINE PAIN QUESTIONNAIRE

MEDICATION GUIDE SUBOXONE (Sub-OX-own) (buprenorphine and naloxone) Sublingual Film for sublingual or buccal administration (CIII)

Basic Medications Activity 1

Stepping toward a different treatment option LEARN WHAT ACTHAR CAN DO FOR YOU

Introduction Hemophilia is a rare bleeding disorder in which the blood does not clot normally. About 1 in 10,000 people are born with hemophilia.

2 What you need to know before you have Ampiclox

Electroconvulsive Therapy - ECT

NEW PATIENT CLINICAL INFORMATION FORM. Booth Gardner Parkinson s Care & Movement Disorders Center Evergreen Neuroscience Institute

STRATTERA (Stra-TAIR-a)

PATIENT MEDICATION INFORMATION

MEDICATION GUIDE POTIGA (po-tee-ga) tablets, CV (ezogabine)

Paracetamol apollo Paracetamol apollo Paracetamol

Heart problems - What are the possible side effects of AVONEX? What is AVONEX? Who should not take AVONEX?

MEDICATION GUIDE. TRINTELLIX [trin -tel-ix] (vortioxetine) Tablets

APPENDIX I-A: INFORMED CONSENT BB IND Protocol CDC IRB #4167

Breast Cancer. Breast Cancer Page 1

Patient Information Leaflet

THE 7:16 WAS ON TIME BUT MY LEGS WERE BEHIND SCHEDULE THAT S WHEN I ASKED FOR THE WALKING PILL

Intestinal Permeability Leaky Gut Syndrome Protocol Dr. Kurt Woeller, D.O.

MEDICATION GUIDE. What is Morphine Sulfate Oral Solution?

Mitoxantrone. For multiple sclerosis. InfoNEURO INFORMATION FOR PATIENTS. Montreal Neurological Hospital

MEDICATION GUIDE Savella (Sa-vel-la) (milnacipran HCl) Tablets

What You Need to KnowWhen Taking Anticoagulation Medicine

Chemotherapy Side Effects Worksheet

MEDICATION GUIDE ZYBAN (zi ban) (bupropion hydrochloride) Sustained-Release Tablets

Bone Marrow or Blood Stem Cell Transplants in Children With Severe Forms of Autoimmune Disorders or Certain Types of Cancer

Leflunomide Leflunomide

2 months Diptheria; Tetanus; Whooping Cough; Hib & Polio 1st dose Pneumococcal Conjugate Vaccination

Multiple sclerosis disease-modifying drugs second line treatments

For the Patient: Protocol LUAJNP Other names: Adjuvant Treatment of Non-Small Cell Lung Cancer with Cisplatin and Vinorelbine

You. guide to tuberculosis treatment and services

TC Chemotherapy Regimen (Docetaxel + Cyclophosphamide)

H1N1 Flu Vaccine Available to All Virginia Beach City Public Schools Students

Patient Information VYTORIN (VI-tor-in) (ezetimibe and simvastatin) Tablets

Medicines To Treat Alcohol Use Disorder A Review of the Research for Adults

ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR DEEP VEIN THROMBOSIS (DVT)

387

Transcription:

1 of 6 6/10/2016 3:52 PM Generic Name: cytarabine (sye TAR a been) Brand Name: Cytosar-U, Tarabine PFS, Cytosar What is cytarabine? Cytarabine is a cancer medication that interferes with the growth and spread of cancer cells in the body. Cytarabine is used to treat certain types of leukemia (blood cancers). Cytarabine is also used to treat leukemia associated with meningitis. Cytarabine will not treat an active meningitis infection that has already developed in the body. Cytarabine may also be used for purposes not listed in this medication guide. What is the most important information I should know about cytarabine? Cytarabine is a cancer medication that interferes with the growth and spread of cancer cells in the body. Cytarabine can cause serious side effects on your brain or central nervous system that may not be reversible. Cytarabine is usually given together with a steroid medication to help lessen these side effects. Talk with your doctor about the risks and benefits of using this medication. Cytarabine can lower blood cells that help your body fight infections and help your blood to clot. You may get an infection or bleed more easily. Call your doctor if you have unusual bruising or bleeding, or signs of infection (fever, chills, body aches). What should I discuss with my healthcare provider before receiving cytarabine? Cytarabine can cause serious side effects on your brain or central nervous system that may not be reversible. Cytarabine is usually given together with a steroid medication to help lessen these side effects. Talk with your doctor about the risks and benefits of using this medication. You should not receive this medication if you are allergic to cytarabine. To make sure you can safely receive cytarabine, tell your doctor if you have any of these other conditions: epilepsy or other seizure disorder; or a history of head injury or brain tumor. Do not receive cytarabine if you are pregnant. It could harm the unborn baby. Use effective birth control, and tell your doctor if you become pregnant during treatment.

2 of 6 6/10/2016 3:52 PM It is not known whether cytarabine passes into breast milk or if it could harm a nursing baby. You should not breast-feed while you are receiving cytarabine. How is cytarabine given? Cytarabine is given as an injection through a needle placed into a vein, under the skin, or into the space around the spinal cord. You will receive this injection in a clinic or hospital setting. Cytarabine is usually given once every 2 to 4 weeks. Follow your doctor's dosing instructions very carefully. Tell your caregivers if you feel any burning, pain, or swelling around the IV needle when cytarabine is injected. After receiving an injection in the space around your spinal cord, you will need to lie flat for at least 1 hour. You will be watched closely during this time to make sure you do not have serious side effects. Cytarabine can lower blood cells that help your body fight infections and help your blood to clot. This can make it easier for you to bleed from an injury or get sick from being around others who are ill. Your blood may need to be tested often. What happens if I miss a dose? Call your doctor for instructions if you miss an appointment for your cytarabine injection. What happens if I overdose? Seek emergency medical attention or call the Poison Help line at 1-800-222-1222. What should I avoid while receiving cytarabine? Avoid being near people who are sick or have infections. Tell your doctor at once if you develop signs of infection. This medicine can pass into body fluids (urine, feces, vomit). For at least 48 hours after you receive a dose, avoid allowing your body fluids to come into contact with your hands or other surfaces. Caregivers should wear rubber gloves while cleaning up a patient's body fluids, handling contaminated trash or laundry or changing diapers. Wash hands before and after removing gloves. Wash soiled clothing and linens separately from other laundry. Do not receive a "live" vaccine while using cytarabine. The vaccine may not work as well during this time, and may not fully protect you from disease. Live vaccines include measles, mumps, rubella (MMR), rotavirus, typhoid, yellow fever, varicella (chickenpox), zoster (shingles), and nasal flu (influenza) vaccine. Cytarabine side effects Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat. Tell your caregivers at once if you have: fever with nausea, vomiting, and headache; problems with your vision or hearing; loss of movement in any part of your body; loss of bowel or bladder control;

3 of 6 6/10/2016 3:52 PM fever, chills, body aches, flu symptoms, sores in your mouth and throat; pale skin, feeling light-headed or short of breath, rapid heart rate, trouble concentrating; confusion, unusual thoughts or behavior; trouble standing or walking, seizure (convulsions); pain or burning when you urinate; a light-headed feeling, like you might pass out; OR feeling very thirsty or hot, being unable to urinate, heavy sweating, or hot and dry skin. Common side effects may include: drowsiness, dizziness, weakness, memory problems; constipation, diarrhea, mild nausea; back pain, pain in your arms or legs; headache; or trouble sleeping (insomnia). This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. See also: Side effects (in more detail) Cytarabine dosing information Usual Adult Dose for Acute Nonlymphocytic Leukemia: As a part of a combination chemotherapy: 100 mg/m2/day by continuous IV infusion (days 1 to 7) or 100 mg/m2 IV every 12 hours (days 1 to 7) with an anthracycline. Usual Adult Dose for non-hodgkin's Lymphoma: Usual Adult Dose for Chronic Myelogenous Leukemia:

4 of 6 6/10/2016 3:52 PM Usual Adult Dose for Acute Myeloid Leukemia: Usual Adult Dose for Leukemia: Usual Adult Dose for Meningeal Leukemia: The manufacturer has stated that doses ranging from 5 mg/m2 to 75 mg/m2 has been used intrathecally and the frequency of administration has varied from once a day for 4 days to once every 4 days. The manufacturer has further stated that 30 mg/m2 every 4 days until cerebrospinal fluid findings were normal, followed by one additional treatment was the therapy most frequently used.

5 of 6 6/10/2016 3:52 PM Some clinicians today recommend 10 to 30 mg intrathecally up to 3 times a week. Usual Pediatric Dose for Acute Nonlymphocytic Leukemia: As a part of a combination chemotherapy: 100 mg/m2/day by continuous IV infusion (days 1 to 7) or 100 mg/m2 IV every 12 hours (days 1 to 7) with an anthracycline. Usual Pediatric Dose for non-hodgkin's Lymphoma: 1 to 3 g/m2 IV every twelve hours for up to 12 doses The IV infusion generally takes place over 1 to 3 hours. The Usual Pediatric Dose for Acute Myeloid Leukemia: 1 to 3 g/m2 IV every twelve hours for up to 12 doses The IV infusion generally takes place over 1 to 3 hours. The Usual Pediatric Dose for Meningeal Leukemia: The manufacturer has stated that doses ranging from 5 mg/m2 to 75 mg/m2 has been used intrathecally and the frequency of administration has varied from once a day for 4 days to once every 4 days. The manufacturer has further stated that 30 mg/m2 every 4 days until cerebrospinal fluid findings were normal, followed by one additional treatment was the therapy most frequently used. However, some clinicians recommend the following age based dosing: <1 year: 20 mg 1 to 2 years: 30 mg 2 to 3 years: 50 mg >3 years: 70 to 75 mg What other drugs will affect cytarabine? Tell your doctor about all medicines you use, and those you start or stop using during your treatment with cytarabine, especially: digoxin, digitalis. This list is not complete. Other drugs may interact with cytarabine, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide. Where can I get more information? Your pharmacist can provide more information about cytarabine. Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed. Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless

6 of 6 6/10/2016 3:52 PM specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist. Copyright 1996-2012 Cerner Multum, Inc. Version: 6.04. Revision Date: 2015-09-22, 7:59:23 AM.